Ani Pharmaceuticals (ANIP) Net Margin Growth (5y) (2016 - 2026)
Ani Pharmaceuticals (ANIP) Net Margin Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,829.00 |
| Mar 31, 2026 | 1,170.00 |
| Dec 31, 2025 | 1,748.00 |
| Sep 30, 2025 | 1,066.00 |
| Jun 30, 2025 | 2,943.00 |
| Mar 31, 2025 | 2,183.00 |
| Dec 31, 2024 | 447.00 |
| Sep 30, 2024 | -2,415.00 |
| Jun 30, 2024 | -1,401.00 |
| Mar 31, 2024 | 1,210.00 |
| Dec 31, 2023 | -894.00 |
| Sep 30, 2023 | -270.00 |
| Jun 30, 2023 | -87.00 |
| Mar 31, 2023 | -387.00 |
| Dec 31, 2022 | -4,370.00 |
| Sep 30, 2022 | -2,741.00 |
| Jun 30, 2022 | -3,242.00 |
| Mar 31, 2022 | -3,785.00 |
| Dec 31, 2021 | -3,436.00 |
| Sep 30, 2021 | -2,813.00 |